3 earlier Form 4 trades (code P or S) here by this insider (3 sales), the last on Feb 23, 2024.
The trade is 22.1% of the 28,060 shares held after it.
No other insider sold within 30 days.
74 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: Chief Human Resources Officer McDonald Colin Patrick sold about $60.1K of CCRN on Mar 11, 2026, the largest insider sale at the company since 2024; 74 funds added in the latest 13F quarter.
3 earlier Form 4 trades (code P or S) here by this insider (3 buys), the last on Aug 30, 2022.
+0.0% median (+0.0% mean) 90-day return after 3 previous buys.
The trade is 0.1% of the 199,832 shares held after it.
No other insider bought within 30 days.
74 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: Director CASH W LARRY bought about $1.6K of CCRN on Dec 9, 2025, the largest insider purchase at the company since 2022; 74 funds added in the latest 13F quarter.
3 earlier Form 4 trades (code P or S) here by this insider (3 buys), the last on Aug 30, 2022.
+0.0% median (+0.0% mean) 90-day return after 3 previous buys.
The trade is 2.3% of the 204,632 shares held after it.
No other insider bought within 30 days.
74 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: Director CASH W LARRY bought about $39.2K of CCRN on Dec 9, 2025, the largest insider purchase at the company since 2022; 74 funds added in the latest 13F quarter.
3 earlier Form 4 trades (code P or S) here by this insider (3 sales), the last on Nov 28, 2023.
The trade is 25.6% of the 7,605 shares held after it.
1 other insider sold within 30 days.
74 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: VP, Corporate Treasurer Grieco Cynthia Ann sold about $33.5K of CCRN on Aug 2, 2024; 1 other insider sold within 30 days and 74 funds added in the latest 13F quarter.
1 earlier Form 4 trade (code P or S) here by this insider (1 sale), the last on Mar 15, 2024.
The trade is 56.0% of the 24,696 shares held after it.
1 other insider sold within 30 days.
74 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: Pres., Cross Country Locums Mote Karen sold about $236.2K of CCRN on Aug 2, 2024; 1 other insider sold within 30 days and 74 funds added in the latest 13F quarter.
38 transactions on record
Since filing: total return from the first close after the filing to the latest close, dividend-adjusted. Not a forecast.
Context lines are counts over the filings above and returns from our own price history, never a price level. Not investment advice.
Ratios from the company's XBRL filings, latest filings
Revenue, TTM
$1.0B
four quarters, 2025-04-01 to 2026-03-31
Revenue, TTM CCRN
FY Dec 2025
$1.1B
FY Dec 2024
$1.3B
FY Dec 2023
$2.0B
FY Dec 2022
$2.8B
FY Dec 2021
$1.7B
Mar 2026
$241.1M
Dec 2025
$236.8M
Sep 2025
$250.1M
Jun 2025
$274.1M
Mar 2025
$293.4M
Dec 2024
$309.9M
Sep 2024
$315.1M
Jun 2024
$339.8M
At each fiscal year end
Single quarter
Net margin, TTM
-9.8%
net income over revenue, 2025-04-01 to 2026-03-31
Net margin, TTM CCRN
FY Dec 2025
-9.0%
FY Dec 2024
-1.1%
FY Dec 2023
+3.6%
FY Dec 2022
+6.7%
FY Dec 2021
+7.9%
Mar 2026
-1.8%
Dec 2025
-35.0%
Sep 2025
-1.9%
Jun 2025
-2.4%
Mar 2025
-0.2%
Dec 2024
-1.2%
Sep 2024
+0.8%
Jun 2024
-4.7%
At each fiscal year end
Single quarter
Free cash flow, TTM
$39.6M
operating cash flow minus capex, 2025-04-01 to 2026-03-31
Free cash flow, TTM CCRN
FY Dec 2025
$40.1M
FY Dec 2024
$111.4M
FY Dec 2023
$234.5M
FY Dec 2022
$125.3M
FY Dec 2021
-$92.8M
Mar 2026
$3.3M
Dec 2025
$16.1M
Sep 2025
$17.9M
Jun 2025
$2.2M
Mar 2025
$3.8M
Dec 2024
$21.7M
Sep 2024
$6.3M
Jun 2024
$79.6M
At each fiscal year end
Single quarter
Debt to equity
0.00x
long-term 2023-12-31 (27 months older than the period end) plus current 2022-12-31 (39 months older than the period end); equity 2026-03-31
Debt to equity CCRN
FY Dec 2025
0.00x
FY Dec 2024
0.00x
FY Dec 2023
0.00x
FY Dec 2022
0.33x
FY Dec 2021
0.63x
Mar 2026
0.00x
Dec 2025
0.00x
Sep 2025
0.00x
Jun 2025
0.00x
Mar 2025
0.00x
Dec 2024
0.00x
Sep 2024
0.00x
Jun 2024
0.00x
At each fiscal year end
Trailing four quarters at each quarter end
Cash flow to debt
n/a
no debt to cover
Cash flow to debt CCRN
FY Dec 2025
n/a
FY Dec 2024
n/a
FY Dec 2023
n/a
FY Dec 2022
0.89x
FY Dec 2021
-0.46x
Mar 2026
n/a
Dec 2025
n/a
Sep 2025
n/a
Jun 2025
n/a
Mar 2025
n/a
Dec 2024
n/a
Sep 2024
n/a
Jun 2024
n/a
At each fiscal year end
Trailing four quarters at each quarter end
Return on equity
-27.0%
TTM net income over average of 2025-03-31 and 2026-03-31
Return on equity CCRN
FY Dec 2025
-25.6%
FY Dec 2024
-3.3%
FY Dec 2023
+15.8%
FY Dec 2022
+50.5%
FY Dec 2021
+58.8%
Mar 2026
-27.0%
Dec 2025
-25.6%
Sep 2025
-3.8%
Jun 2025
-2.0%
Mar 2025
-4.0%
Dec 2024
-3.3%
Sep 2024
-0.4%
Jun 2024
+1.9%
At each fiscal year end
Trailing four quarters at each quarter end
Return on assets
-19.2%
TTM net income over average of 2025-03-31 and 2026-03-31
Return on assets CCRN
FY Dec 2025
-18.3%
FY Dec 2024
-2.3%
FY Dec 2023
+8.9%
FY Dec 2022
+22.4%
FY Dec 2021
+24.2%
Mar 2026
-19.2%
Dec 2025
-18.3%
Sep 2025
-2.8%
Jun 2025
-1.4%
Mar 2025
-2.9%
Dec 2024
-2.3%
Sep 2024
-0.3%
Jun 2024
+1.2%
At each fiscal year end
Trailing four quarters at each quarter end
Return on invested capital
n/a
pre-tax loss, no effective tax rate to apply
Return on invested capital CCRN
FY Dec 2025
n/a
FY Dec 2024
n/a
FY Dec 2023
+17.7%
FY Dec 2022
+38.0%
FY Dec 2021
+33.8%
Mar 2026
n/a
Dec 2025
n/a
Sep 2025
n/a
Jun 2025
n/a
Mar 2025
n/a
Dec 2024
n/a
Sep 2024
n/a
Jun 2024
+2.2%
At each fiscal year end
Trailing four quarters at each quarter end
Return on capital employed
-21.2%
operating income (EBIT proxy) over average of 2025-03-31 and 2026-03-31 minus current liabilities
Return on capital employed CCRN
FY Dec 2025
-20.1%
FY Dec 2024
-3.4%
FY Dec 2023
+18.9%
FY Dec 2022
+44.8%
FY Dec 2021
+35.0%
Mar 2026
-21.2%
Dec 2025
-20.1%
Sep 2025
-3.5%
Jun 2025
-1.6%
Mar 2025
-4.2%
Dec 2024
-3.4%
Sep 2024
-0.0%
Jun 2024
+3.3%
At each fiscal year end
Trailing four quarters at each quarter end
P/E, trailing
n/a
trailing loss, a multiple of a loss is not meaningful
P/E, trailing CCRN
FY Dec 2025
n/a
FY Dec 2024
n/a
FY Dec 2023
11.15x
FY Dec 2022
5.30x
FY Dec 2021
7.86x
Mar 2026
n/a
Dec 2025
n/a
Sep 2025
n/a
Jun 2025
n/a
Mar 2025
n/a
Dec 2024
n/a
Sep 2024
n/a
Jun 2024
60.17x
At each fiscal year end
Trailing four quarters at each quarter end
Enterprise value
$322.8M
market value at close 2026-07-28 on 2026-04-24 shares, plus long-term 2023-12-31 (27 months older than the period end) plus current 2022-12-31 (39 months older than the period end), minus cash 2026-03-31
Enterprise value CCRN
FY Dec 2025
$156.6M
FY Dec 2024
$516.1M
FY Dec 2023
$778.7M
FY Dec 2022
$1.1B
FY Dec 2021
$1.1T
Mar 2026
$198.2M
Dec 2025
$156.6M
Sep 2025
$366.1M
Jun 2025
$346.6M
Mar 2025
$407.5M
Dec 2024
$516.1M
Sep 2024
$390.4M
Jun 2024
$411.7M
At each fiscal year end
Trailing four quarters at each quarter end
FCF yield
+9.2%
TTM free cash flow over market value at close 2026-07-28
FCF yield CCRN
FY Dec 2025
+15.1%
FY Dec 2024
+18.6%
FY Dec 2023
+29.5%
FY Dec 2022
+12.6%
FY Dec 2021
-0.0%
Mar 2026
+13.0%
Dec 2025
+15.1%
Sep 2025
+9.8%
Jun 2025
+8.0%
Mar 2025
+22.8%
Dec 2024
+18.6%
Sep 2024
+21.8%
Jun 2024
+33.1%
At each fiscal year end
Trailing four quarters at each quarter end
PEG, trailing
n/a
trailing loss, a multiple of a loss is not meaningful
PEG, trailing CCRN
FY Dec 2025
n/a
FY Dec 2024
n/a
FY Dec 2023
n/a
FY Dec 2022
0.13x
FY Dec 2021
n/a
Mar 2026
n/a
Dec 2025
n/a
Sep 2025
n/a
Jun 2025
n/a
Mar 2025
n/a
Dec 2024
n/a
Sep 2024
n/a
Jun 2024
n/a
At each fiscal year end
Trailing four quarters at each quarter end
Price as of 2026-07-28. Hover or tap a tile for its yearly and quarterly history.Method
TTM is four consecutive fiscal quarters; Q4 is the year minus nine months when not filed. Returns use the average of opening and closing balances. EBIT is approximated by operating income. PEG uses trailing EPS growth.
Fundamentals
Annual figures from XBRL filings. Pick a past date to see them as known then.
CCRN ranks highest on financial health (99th percentile) and institutional and government (29th), and lowest on growth (11th), among Services peers.
Profitability
22
Inputs
Return on equity-27.0% · 21 pct, sector of 207
Return on assets-19.2% · 26 pct, sector of 269
Return on invested capitalpre-tax loss, no effective tax rate to apply
Return on capital employed-21.2% · 19 pct, sector of 203
Financial health
100
Inputs
Debt to equity0.00x · 100 pct, sector of 228
Cash flow to debtno debt to cover
Growth
11
Inputs
Revenue growth, YoY-21.6% · 11 pct, sector of 341
Backlog growth, YoYno backlog line filed, or no year-earlier backlog
Institutional and government
29
Inputs
Funds adding, latest quarter74 · 45 pct, sector of 243
Congress net buyers, 365dno Congress trades in 365 days
Federal contracts, 180dno federal contracts in 180 days
Lobbying spend, 4 quarters$80K · 12 pct, sector of 61
Risk and compliance
17
Inputs
Short interest, % of floatno short interest or no free float on file
Recalls per $1B revenue, 3ynot measured for this sector, almost no peer has an event
EPA cases per $1B revenue, 5ynot measured for this sector, almost no peer has an event
New text in Risk Factors, latest 10-K+22.1% · 17 pct, sector of 227
2 not measured: Insider conviction, US patents
Insider conviction needs 1 of 2 inputs, 0 present: no Form 4 purchase or sale (code P or S) in 180 days; no insider trades in 180 days
US patents needs 1 of 2 inputs, 0 present: patent data not loaded yet
5 of 7 axes scored. Each is a percentile against sector peers (all companies when the sector is thin); higher is better. An unscored axis is unmeasured, not low. How it is scored
Explore insider trading and ownership data
Every company we track, ranked by each kind of filing
No password to create and no card required. We store your email address, your watchlist and your preferences, nothing else.
PRIVACY & COOKIES
We track filings, not you.
Essential cookies keep you signed in and remember this choice.
Google Analytics 4 and Microsoft Clarity load only if you allow them here; they
count visits and record how pages are used. We run no advertising and never sell
data. Details in the privacy policy. Change this any time
via "Cookie settings" in the footer.